Li Y - Search Results

1

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.

Li Y, Sharma A, Maciaczyk J, Schmidt-Wolf IGH. Li Y, et al. Int J Mol Sci. 2022 Jan 24;23(3):1311. doi: 10.3390/ijms23031311. Int J Mol Sci. 2022. PMID: 35163235 Free PMC article. Review.

2

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.

Dehno MN, Li Y, Weiher H, Schmidt-Wolf IGH. Dehno MN, et al. Among authors: li y. Int J Mol Sci. 2020 Apr 27;21(9):3078. doi: 10.3390/ijms21093078. Int J Mol Sci. 2020. PMID: 32349280 Free PMC article.

3

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding.

Wu X, Zhang Y, Li Y, Schmidt-Wolf IGH. Wu X, et al. Among authors: li y. Cancers (Basel). 2020 Jul 7;12(7):1818. doi: 10.3390/cancers12071818. Cancers (Basel). 2020. PMID: 32645836 Free PMC article.

4

Improvements in Flow Cytometry-Based Cytotoxicity Assay.

Wu X, Zhang Y, Li Y, Schmidt-Wolf IGH. Wu X, et al. Among authors: li y. Cytometry A. 2021 Jul;99(7):680-688. doi: 10.1002/cyto.a.24242. Epub 2020 Oct 31. Cytometry A. 2021. PMID: 33068327 Free article.

5

PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines.

Li Y, Sharma A, Bloemendal MWJR, Schmidt-Wolf R, Kornek M, Schmidt-Wolf IGH. Li Y, et al. Oncol Lett. 2021 Aug;22(2):613. doi: 10.3892/ol.2021.12874. Epub 2021 Jun 23. Oncol Lett. 2021. PMID: 34257721 Free PMC article.

6

A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.

Li Y, Sharma A, Wu X, Weiher H, Skowasch D, Essler M, Schmidt-Wolf IGH. Li Y, et al. Front Oncol. 2022 May 11;12:713476. doi: 10.3389/fonc.2022.713476. eCollection 2022. Front Oncol. 2022. PMID: 35646685 Free PMC article.

7

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors.

Vaseq R, Sharma A, Li Y, Schmidt-Wolf IGH. Vaseq R, et al. Among authors: li y. Int J Mol Sci. 2023 Mar 15;24(6):5626. doi: 10.3390/ijms24065626. Int J Mol Sci. 2023. PMID: 36982701 Free PMC article. Review.

8

Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

Li Y, Sharma A, Hoffmann MJ, Skowasch D, Essler M, Weiher H, Schmidt-Wolf IGH. Li Y, et al. Front Immunol. 2024 Mar 14;15:1268652. doi: 10.3389/fimmu.2024.1268652. eCollection 2024. Front Immunol. 2024. PMID: 38558822 Free PMC article.

9

Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer.

Li Y, Sharma A, Schmidt-Wolf IGH. Li Y, et al. Mol Cancer. 2024 Apr 24;23(1):80. doi: 10.1186/s12943-023-01926-4. Mol Cancer. 2024. PMID: 38659003 Free PMC article. Review.

10

The effects of diacylglycerol edible oil intervention in patients with chronic metabolic syndrome combined with asymptomatic hyperuricemia: study protocol for a multicenter, prospective, double-blind, randomized controlled trial.

Li GY, Zhu CF, Huang ZQ, Piao CL, Yu JJ, Wang L, Zeng Q, Lei YY, Li Y, Zhu XL, Zhang ZT, Huang TH, Li MS, Lin SZ, Zhang NW, Zhang F, Wang YH, Xu DP. Li GY, et al. Among authors: li y. Trials. 2025 Jan 13;26(1):16. doi: 10.1186/s13063-024-08638-0. Trials. 2025. PMID: 39806511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,890 results

Search Page

Filters